CGON R&D to Revenue
Cg Oncology Inc · R&D to Revenue
CGON R&D to Revenue
Latest reported2887.15%period ending
CGON FY R&D/Revenue (176.86% → 2887.15%)
Latest values, visible window
High-resolution chart · PNG
CGON r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 2,887.1535% | |
| 7,208.2529% | |
| 22,427.451% | |
| 15,198.4293% | |
| 176.8585% |